赤子城科技(09911.HK)续挫10%曾失50天线 料全年盈利跌30%-50%
债息进一步飙升,美国高市值科技股连日捱沽,本港科技股也连续两天捱沽。料全年盈利至少减三成的赤子城科技(09911.HK)三连跌,今早曾失守50天线(4.07元),最低见3.8元,现造4.1元,续挫10%,成交仍达4,065万股,涉资1.62亿元。
赤子城昨天预计,截至去年底止全年纯利按年减少30%-50%至介乎3,300-4,700万人民币,主因是以股份为基础报酬开支及研发费用增加所致。不过,全年总收入按年升1.8-2.2倍至11-12.5亿人民币。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.